Trifecta Capital Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$115K Sell
1,200
-1,150
-49% -$110K 0.01% 145
2026
Q1
$244K Buy
+2,350
New +$266K 0.04% 93
2025
Q4
Sell
-13
Closed -$1.6K 296
2025
Q3
$1.6K Hold
13
﹤0.01% 366
2025
Q2
$1.56K Hold
13
﹤0.01% 375
2025
Q1
$1.92K Sell
13
-80
-86% -$12.2K ﹤0.01% 319
2024
Q4
$15.1K Hold
93
﹤0.01% 201
2024
Q3
$15.2K Sell
93
-130
-58% -$19.3K ﹤0.01% 203
2024
Q2
$30.4K Buy
223
+130
+140% +$18.1K 0.01% 166
2024
Q1
$14.2K Hold
93
﹤0.01% 190
2023
Q4
$13.3K Hold
93
﹤0.01% 195
2023
Q3
$12.2K Hold
93
﹤0.01% 206
2023
Q2
$14.8K Hold
93
﹤0.01% 195
2023
Q1
$14.7K Hold
93
0.01% 199
2022
Q4
$13.1K Buy
+93
New +$13.2K 0.01% 185

Other funds holding CLX

Trifecta Capital Advisors's CLX Position: Q2 2026 in Review

Trifecta Capital Advisors reduced its Clorox (CLX) stake by 49% in Q2 2026, selling an estimated $110K and leaving 1,200 shares worth $115K. The position accounts for 0.01% of the portfolio, ranked #145.

Trifecta Capital Advisors first reported a position in CLX in Q4 2022 and has held it in 14 quarters since. The position peaked at $244K in Q1 2026. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Trifecta Capital Advisors held 1,200 shares of Clorox worth $115K as of Q2 2026.
  • Trifecta Capital Advisors sold 1,150 Clorox shares in Q2 2026, an estimated $110K.
  • Clorox made up 0.01% of Trifecta Capital Advisors's portfolio in Q2 2026, its #145 holding.
  • Trifecta Capital Advisors first reported a position in Clorox in Q4 2022 and has held it in 14 quarters since.
  • Trifecta Capital Advisors's Clorox position peaked at $244K in Q1 2026.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Trifecta Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.